Corteva (NYSE:CTVA) Given New $10.00 Price Target at UBS Group

Corteva (NYSE:CTVA) had its target price cut by equities researchers at UBS Group from $15.00 to $10.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group‘s target price would indicate a potential upside of 9.11% from the stock’s current price.

A number of other equities analysts also recently issued reports on the company. The Goldman Sachs Group reiterated a “buy” rating and set a $20.00 price target on shares of Corteva in a research report on Thursday, October 8th. Deutsche Bank restated a “buy” rating and issued a $101.00 price objective on shares of Corteva in a research report on Monday, August 3rd. Morgan Stanley reaffirmed an “overweight” rating and set a $18.00 target price on shares of Corteva in a research note on Friday, October 2nd. KeyCorp upgraded Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 target price on the stock in a research report on Wednesday, October 7th. Finally, Bank of America lifted their price target on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Fifteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $56.41.

Corteva Price Performance

Shares of Corteva stock traded down $0.03 on Friday, hitting $9.16. The company’s stock had a trading volume of 7,972,102 shares, compared to its average volume of 8,291,812. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva has a 1 year low of $9.01 and a 1 year high of $90.97. The firm has a fifty day moving average price of $38.81 and a 200-day moving average price of $69.88. The company has a market capitalization of $6.11 billion, a price-to-earnings ratio of 6.06, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58.

Hedge Funds Weigh In On Corteva

A number of hedge funds have recently made changes to their positions in the company. Xcelsior Advisor Partners LLC lifted its position in Corteva by 26.6% during the 3rd quarter. Xcelsior Advisor Partners LLC now owns 24,281 shares of the company’s stock worth $1,885,000 after acquiring an additional 5,107 shares during the period. Bleakley Financial Group LLC increased its holdings in shares of Corteva by 12.5% in the third quarter. Bleakley Financial Group LLC now owns 18,309 shares of the company’s stock valued at $1,422,000 after purchasing an additional 2,032 shares during the period. N.F.U. MUTUAL UNIT MANAGERS Ltd acquired a new position in shares of Corteva in the third quarter valued at approximately $1,325,000. Gabelli Funds LLC raised its stake in shares of Corteva by 32.9% during the third quarter. Gabelli Funds LLC now owns 46,500 shares of the company’s stock worth $3,611,000 after purchasing an additional 11,500 shares during the last quarter. Finally, Advisors Asset Management Inc. purchased a new stake in shares of Corteva during the third quarter worth approximately $2,856,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Top Corteva Stories

Investors following CTVA have been watching these stories:

• Neutral Sentiment: Royal Bank of Canada lowered its price target from $17 to $11 but maintained an “outperform” rating, indicating the analyst still sees potential upside despite reducing its valuation. Royal Bank of Canada rating and price target
• Negative Sentiment: Brazil’s inventory glut, weaker demand, competitive pricing and lower volumes are weighing on sales and earnings. Corteva cut its 2026 adjusted EPS guidance to $0.76–$0.80, below the cited analyst consensus of $1.07; its shares fell sharply following the results and outlook update. Corteva shares slide after Brazil weakness prompts annual profit forecast cut
• Negative Sentiment: A law firm announced an investigation into whether Corteva violated securities laws. The announcement adds a legal overhang, though it is an investigation—not a finding of wrongdoing. Securities fraud investigation announcement

Corteva Company Profile

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.